Trial Profile
A study of DUR-928 for kidney disease.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Larsucosterol (Primary)
- Indications Kidney disorders
- Focus Adverse reactions
- 23 Feb 2017 New trial record